In-line Filtration Reduces Postoperative Phlebitis.
1 other identifier
interventional
268
0 countries
N/A
Brief Summary
The aim of this study is to demonstrate the efficacy of in-line filtration in reducing the incidence of postoperative phlebitis associated with peripheral short-term vascular access. In this controlled trial, 268 surgical patients are 1:1 randomised to in-line filtration (study group) and standard care (control group). The incidence of phlebitis (defined as Visual Infusion Phlebitis, VIP score≥2) within 48hrs postoperatively is compared between the two groups, as well as the onset and severity of phlebitis and the reasons for removal of the cannula. The lifespan of venous cannulae and cost-of-care are compared for the study and control groups through a Kaplan-Meier curve. Multivariate Cox regression analysis is performed to evaluate the effect of in-line filtration on risk of phlebitis and cannula removal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2017
CompletedFirst Submitted
Initial submission to the registry
June 18, 2017
CompletedFirst Posted
Study publicly available on registry
June 21, 2017
CompletedJune 21, 2017
June 1, 2017
7 months
June 18, 2017
June 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The aim of the trial is to demonstrate the efficacy of in-line filtration in reducing the incidence of postoperative phlebitis associated with peripheral short-term vascular access in the 48 postoperative hours
The incidence of phlebitis is evaluated through Visual Infusion Phlebitis (VIP) score.Phlebitis is defined as a VIP score ≥ 2. A Fischer's exact test will be use to evaluate difference between study group and control group.
VIP score is evaluated every 12hrs from the end of surgery until 96 hrs postoperatively
Secondary Outcomes (3)
A secondary objective is to evaluate difference between study group and control group phlebitis onset in the 96 postoperative hours
VIP score is evaluated every 12hrs from the end of surgery until 96 hrs postoperatively
A secondary objective is to show difference between study group and control group phlebitis severity in the 96 postoperative hours
VIP score is evaluated every 12hrs from the end of surgery until 96 hrs postoperatively
A secondary objective is to evaluate care cost increase secondary to in-line filtration management between study group and control group
In 96 postoperative hours, all materials used (infusion sets, vascular dressing devices, filters, kit for venipuncture...) to manage vascular access in control group and in study group is registered
Study Arms (2)
study group
EXPERIMENTALIn this group in-line filters (Pall, Dreieich, Germany) are connected to peripheral vascular access and used during anaesthesia and the following 96 postoperative hours.
control group
ACTIVE COMPARATORPatients randomised to standard care are managed without an in-line filter and according to local routine practice for intravenous drug administration in the adult patient.
Interventions
In-line filtration is used during anesthesia and postoperative 96 hrs in study group to purify endovascular fluids administrations reducing postoperative phlebitis
Patients are treated with standard intravenous solutions and vascular access management
Eligibility Criteria
You may qualify if:
- Age\>18 years old
- Consent to trial participation and randomization obtained in preoperative period
You may not qualify if:
- Pregnancy
- Presence of central vascular access with central or peripheral iserction
- Presence of long peripheral vascular access such as Midline or MiniMidline
- Patients envolved in other comparative trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Careggi Hospitallead
Related Publications (2)
Niel-Weise BS, Stijnen T, van den Broek PJ. Should in-line filters be used in peripheral intravenous catheters to prevent infusion-related phlebitis? A systematic review of randomized controlled trials. Anesth Analg. 2010 Jun 1;110(6):1624-9. doi: 10.1213/ANE.0b013e3181da8342. Epub 2010 Apr 30.
PMID: 20435946RESULTVilla G, Chelazzi C, Giua R, Tofani L, Zagli G, Boninsegni P, Pinelli F, De Gaudio AR, Romagnoli S. In-Line Filtration Reduces Postoperative Venous Peripheral Phlebitis Associated With Cannulation: A Randomized Clinical Trial. Anesth Analg. 2018 Dec;127(6):1367-1374. doi: 10.1213/ANE.0000000000003393.
PMID: 29697508DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 18, 2017
First Posted
June 21, 2017
Study Start
November 1, 2016
Primary Completion
June 1, 2017
Study Completion
June 10, 2017
Last Updated
June 21, 2017
Record last verified: 2017-06
Data Sharing
- IPD Sharing
- Will not share